FluoSphera

🚠 13 Swiss Medtech Startups Shine at TOP 100 Awards! Huge congrats to the 13 innovative Medtech startups who impressed the TOP 100 Swiss Startup Award Jury in 2024! These companies are pushing the boundaries of healthcare with solutions for stroke treatment, early disease detection, and personalized medicine. 🫁 ❤️ Women+ in MedTeCH wants to give them a voice: We're excited to announce that we'll be conducting a series of micro interviews with the CEOs of these groundbreaking Medtech startups that made it into the TOP 100! ❓ Which CEO would you like to hear from? 👉 Enter your vote here: https://lnkd.in/du52S8WP 🔹️Nanoflex Robotics (#10) - Soft robotic system for precise catheter movement 🔹️Avelo (#12) - Breath collector for early diagnosis of respiratory issues 🔹️Artiria Medical (#31) - Minimally invasive tech for stroke treatment 🔹️Adiposs (#35) - Imaging brown adipose tissue for metabolic health 🔹️FluoSphera (#39) - Drug safety & efficacy prediction platform 🔹️Neurosoft Bioelectronics (#46) - Soft, implantable electrodes for nervous tissue 🔹️EarlySight (#48) - Unprecedented eye imaging for early disease detection 🔹️ENANTIOS (#53) - Faster drug development & quality testing 🔹️CustomSurg (#55) - Data-driven pre-operative planning for surgeries 🔹️Terapet SA (#63) - Next-level nuclear medicine platform for precision therapy 🔹️TWIICE (#70) - World's most advanced exoskeleton for mobility restoration 🔹️Bottneuro AG (#82) - Personalized neurostimulation therapy for various conditions 🔹️Herosupport SA (#94) - Personalized patient-positioning devices for cancer treatment #TOP100SSU #SwissStartup #Medtech #innovation #healthcare #WomenAndBeyondInMedTeCH

FluoSphera & Spirochrome: Episode 3 🎥 We're excited to unveil the latest chapter in our collaboration with Spirochrome! Together, we’re bringing their state-of-the-art nuclear SPY probes into FluoSphera's 3D co-cultures. In this episode, we show the staining of nuclei from a co-culture of encapsulated colon cancer spheroids (purple), breast cancer spheroids (red), and liver spheroids (green) with nuclear SPY probes. The result? A perfect identification of cell types and nuclei with vivid colors! 🌈 These advanced nuclear SPY probes offer: ✨ Seamless compatibility with our systems, allowing precise visualization 🔬 that lasts for days, with zero toxicity and no photobleaching. ✨ Stay tuned for Episode 4, where we’ll showcase an application using an anti-cancer molecule on 3 different cell lines in co-culture! 🎬 #FluoSphera #Spirochrome #DrugDiscovery #3DCellCulture #Innovation #ImagingRevolution

Join us at Investival Showcase in London on November 18th, 2024, where FluoSphera will be connecting with leaders, innovators, and investors who are committed to advancing breakthrough solutions in drug discovery. This event is all about building meaningful partnerships that drive impact and innovation in biotechnology and healthcare. 💊 Let’s push the boundaries of what’s possible! 🚀 📅 Date: November 18th 📍 Event: Investival Showcase, London See you there!🤝

🚀 FluoSphera is presenting to the Global Medicines & Biotechnology Summit in Riyadh (RGMBS 2024)! 🚀   We're thrilled to share that we’ve been invited to present our innovative technology at this prestigious event, showcasing FluoSphera's cutting-edge platform for systemic in vitro drug discovery. 🌐💡 Join us to see how our technology is revolutionizing #oncology drug development by enabling researchers to make better-informed decisions on #ADC molecules and beyond! 🔬💊 📅 Date: November 10-12th 📍 Location: Global Medicines & Biotechnology Summit, Riyadh ✨ Don’t miss out on the chance to connect with us! Looking forward to connecting with investors, fellow innovators, and industry leaders! Let’s drive the future of drug discovery together! 🌟🤝 #FluoSphera #RGMBS2024 #DrugDiscovery #Oncology #ADCTesting #Innovation #RiyadhSummit

🚨 The SWISS BIOTECH Pavilion at #BIOEurope2024 kicks-off with a total of 33 exhibitors, in Stockholm, taking place until wednesday! 🌍💊 At one of the largest and most internationally diverse events in the global biopharmaceutical industry, you can discover innovative solutions and cutting-edge breakthroughs from leading Swiss brands and the following start-ups supported by Innosuisse: Amphilix AG, ASTRA Therapeutics, Cellestia Biotech cellvie, FluoSphera, HekeTiss, InCephalo, Isospec Analytics, metaLead, MPC Therapeutics, Nagi Bioscience, NXI Therapeutics AG, Reconnect Labs Synendos Therapeutics AG, Topadur Pharma AG, Vandria SA Engage with innovative biotech and pharma technologies that are shaping the future of healthcare and life-sciences! Switzerland Global Enterprise Swiss Biotech Ltd Swiss Biotech Association Swiss Business Hub Nordics

🚨 The SWISS BIOTECH Pavilion at #BIOEurope2024 is in full swing with a total of 33 exhibitors, in Stockholm, taking place from 04-06 November 2024!   🌍💊 At one of the largest and most internationally diverse events in the global biopharmaceutical industry, you can discover innovative solutions and cutting-edge breakthroughs from leading Swiss brands and the following start-ups supported by Innosuisse: Amphilix AG ASTRA Therapeutics Cellestia Biotech cellvie FluoSphera HekeTiss InCephalo Isospec Analytics metaLead Therapeutics MPC Therapeutics Nagi Bioscience NXI Therapeutics AG Reconnect Labs Synendos Therapeutics AG Topadur Pharma AG Vandria SA   In addition to the companies supported by Innosuisse, the following exhibitors are also represented in Stockholm: Baccinex SA, Bioengineering AG, BioVersys AG, Economic Promotion Valais EPIC Suisse AG, Ewopharma, Greater Geneva Bern area (GGBa), Healthecon AG - Ein Unternehmen der IGES-Gruppe, InsideReg, InSphero ,Molecular Partners AG, OM Pharma,PDC Therapeutics, Regen Lab, Superlab Suisse, Translation-X, Venture Valuation AG The full list of exhibitors is available here: https://lnkd.in/dA9Q3c5K An excellent opportunity to engage with innovative biotech and pharma technologies that are shaping the future of healthcare and life-sciences 🎉 #Bioeurope #swissinnovation #biopharma Swiss Biotech Association Swiss Business Hub Nordics

Here we are! The World ADC Event Series Conferences begin in just a few hours, and FluoSphera has a full agenda of exciting meetings with #ADC developers from across the globe. We are ready to unveil our disruptive solutions, set to make a lasting impact on the future of ADCs. Our goal: to boost clinical success rates, bringing real benefits to patients worldwide.

🚀 Unleashing the Next Generation of ADCs! 🚀 FluoSphera is thrilled to announce the expansion of its systemic technology platform into Antibody-Drug Conjugate (ADC) testing! Our first-in-human predictive tools are here to transform ADC development, boosting precision, optimizing clinical outcomes, and paving the way for the future of oncology.

🚀 Proud to be ranked among the most promising Swiss MedTech Startups of 2024! A huge thank you to our incredible team, supporters, partners, and investors! 🙏